中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

MMP-9 Expression in Permanent Mature Teeth With Symptomatic Pulpitis

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Eglė Gvazdaitytė

关键词

抽象

Matrix metallopeptidase-9 (MMP-9) expression was compared in healthy and inflamed pulp and the outcome of coronal pulpotomy in teeth with symptomatic pulpitis was assessed. After procedure blood samples were examined using Elisa kit.

描述

Introduction: Widely used diagnostic tests do not provide information to distinguish the pulp inflammation stage while improvement of materials, techniques and vital pulp therapy have received a wider acceptance in symptomatic pulpitis treatment. The aim of this clinical study was to compare MMP-9 expression in healthy and inflamed pulp and to assess the short-term outcome of coronal pulpotomy in mature permanent teeth with symptomatic pulpitis.

Methods: Patients diagnosed with symptomatic pulpitis were included in this clinical study. Coronal pulpotomy was performed using calcium-silicate based material and blood samples were taken. Initial and postoperative pain was recorded by Heft-Parker visual analog scale at 24 hours and 72 hours after the procedure. In control group teeth with healthy pulp were used. During follow-up visits after three and six-months, patients were examined clinically and radiographically. The ELISA kit was used to determine the levels of MMP-9 in inflamed and healthy coronal pulp tissue.

日期

最后验证: 12/31/2018
首次提交: 11/18/2018
提交的预估入学人数: 01/13/2019
首次发布: 01/16/2019
上次提交的更新: 01/13/2019
最近更新发布: 01/16/2019
实际学习开始日期: 03/26/2017
预计主要完成日期: 07/14/2017
预计完成日期: 02/10/2018

状况或疾病

Pulpitis

干预/治疗

Procedure: Coronal pulpotomy

-

手臂组

干预/治疗
Other: Control group - Healthy teeth
Patients with clinically healthy third molar or premolar teeth with indications for extraction; no clinical signs of pulpitis, no caries, no indications for the replacement of an old filling that is 1 mm from the pulp space as determined on the radiograph; a normal response to the cold test, and no apical radiolucency on the radiograph. For teeth of this group coronal pulpotomy was applied.
Experimental: Test group - Teeth with pulpitis
Patients with symptomatic pulpitis resulting from caries; tooth pain defined as sharp, dull, localized or diffuse; pain at night; a symptomatic tooth with a positive response to the cold test and lingering pain; intermittent or continuous episodes of spontaneous pain (with no external stimulus) that could last from a few minutes up to a few hours; no apical radiolucency on the radiograph. For teeth of this group coronal pulpotomy was applied.

资格标准

有资格学习的年龄 14 Years 至 14 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Teeth diagnosed with symptomatic pulpitis

- Patients who did not use any NSAIDs before the treatment

- Positive cold test of investigated teeth

- Clinically dental caries in contact with pulp chamber

- Permanent teeth with radiographically closed root apex

Exclusion Criteria:

- Patients who refuse to participate in the study

- Medically compromised patients (with immunosuppressive/systemic diseases, patients on medications)

- Teeth with periapical radiolucency or clinical signs of apical periodontitis

- Periodontological compromised teeth (probing depth ≥4mm)

- Internal/external root resorption in periapical radiograph

- Pulp chamber and/or root canal calcification in periapical radiograph

- Teeth with unrestorable crown

- Teeth with a negative response to cold test

结果

主要结果指标

1. MMP-9 amount measurement using ELISA kit [All samples were measured in one time (during 12 hours)]

The MMP-9 amount in the pulp blood samples was measured using the MMP-9 Human ELISA Kit. The measurement procedure was followed according to the manufacturer's instructions. The anti-MMP-9 polyclonal antibody was pre-coated on 96-well plates. Blood samples and a biotin-conjugated antibody were added to the wells supplemented with Avidin-Biotin-Peroxidase Complex and 3,3',5,5'-tetramethylbenzidine in a mildly acidic buffer. A blue-colored product was produced and turned to yellow after an acidic stop solution was added. The intensity of the color yellow was proportional to the MMP-9 amount bound on the plate. The optical density absorbance was measured spectrophotometrically at 450nm in a microplate reader and the concentration of MMP-9 was calculated. For the expression of MMP-9 concentrations in the samples, a standard curve was used.

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge